Acne Vulgaris-Novel Treatment Options and Factors Affecting Therapy Adherence: A Narrative Review.

J Clin Med

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Chałubińskiego 1, 50-368 Wrocław, Poland.

Published: December 2022

Acne vulgaris is an extremely common skin condition, affecting a large population of adolescents, but at the same time, remaining a quite common issue in the group of adult patients. Its complex pathogenesis includes increased sebum secretion, impaired follicular keratinization, colonization of sebaceous glands with bacteria, and the development of inflammation in pilosebaceous units. Although there are many methods of treatment available targeting the mechanisms mentioned above, a large percentage of patients remain undertreated or non-compliant with treatment. Ineffective treatment results in the formation of acne scars, which has a major impact on the well-being and quality of life of the patients. The aim of this publication was a review of available evidence on widely used and novel methods of topical and systemic treatment of acne, additionally including current literature-based analysis of factors affecting patients' compliance. The strengths and limitations of novel substances for treating acne were discussed. We conclude that an effective acne treatment remains a challenge. A better understanding of current treatment options and factors affecting patients' compliance could be a helpful tool in choosing a proper treatment option.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788443PMC
http://dx.doi.org/10.3390/jcm11247535DOI Listing

Publication Analysis

Top Keywords

treatment
8
treatment options
8
options factors
8
factors patients'
8
patients' compliance
8
acne
6
acne vulgaris-novel
4
vulgaris-novel treatment
4
factors therapy
4
therapy adherence
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!